Registrations have closed.
Molecular Residual Disease (MRD): Exploring the Impact on Cancer Early Detection and Personalized Care
423
423 people viewed this event.
In this session from the Prevent Cancer Foundation, speakers will delve into the cutting-edge science of Molecular Residual Disease (MRD) testing, a revolutionary approach to cancer detection. They will explore how these tests can help determine prognosis/relapse risk, find early recurrence and individualize treatment to improve patient outcomes.